Cumberland Pharmaceuticals, Inc. ( NASDAQ: CPIX) Q1 2025 Earnings Conference Call May 6, 2024 4:30 PM ET Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - CEO Todd Anthony - VP, ...

Discover how alternative investments are reshaping wealth management with insights on diversification, risk mitigation, and ...

Trinity Capital trades at a compelling valuation after a year of price declines, with steady earnings and low non-accruals.

Clearwater Paper's asset shuffle, debt reduction, and strong cash flow ambitions make it a top buy under $30, with rebound ...

Guess navigates U.S.–China trade tensions, uneven segment performance, and European margins. See why we are neutral on GES ...

Dollarama expands globally with The Reject Shop acquisition in Australia and Dollarcity growth in Latin America. Read an ...

Trading activity on the Tradeweb European ETF marketplace amounted to an all-time record of EUR 98 billion in April.

Powell Industries (POWL) is a strong long-term investment with robust demand, a $1.3B backlog, and growth prospects in ...

Meta Platforms is upgraded to buy. Strong AI investments, bullish technicals, and solid Q1 results signal long-term growth.

Builders FirstSource (BLDR) faces challenges with 1Q25 sales declines, margin pressure, and weak housing markets. Read here ...

We sometimes refer to productivity as “the most important macroeconomic data point that nobody pays attention to.” ...

ATI's strong Q1 results, share buybacks, and projected double-digit earnings growth make it a good investment candidate. See ...